- Report
- September 2023
- 143 Pages
Global
From €3222EUR$3,599USD£2,744GBP
- Report
- June 2023
- 140 Pages
Global
From €4430EUR$4,949USD£3,774GBP
- Report
- April 2023
- 147 Pages
Global
From €4430EUR$4,949USD£3,774GBP
- Report
- April 2023
- 147 Pages
Global
From €4430EUR$4,949USD£3,774GBP
- Report
- April 2023
- 147 Pages
Global
From €4430EUR$4,949USD£3,774GBP
- Report
- March 2023
- 147 Pages
Global
From €4430EUR$4,949USD£3,774GBP
- Report
- March 2023
- 147 Pages
Global
From €4430EUR$4,949USD£3,774GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4431EUR$4,950USD£3,774GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4431EUR$4,950USD£3,774GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4431EUR$4,950USD£3,774GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4431EUR$4,950USD£3,774GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4431EUR$4,950USD£3,774GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4431EUR$4,950USD£3,774GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4431EUR$4,950USD£3,774GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4431EUR$4,950USD£3,774GBP
- Report
- January 2024
- 189 Pages
Global
From €6714EUR$7,500USD£5,719GBP
- Report
- January 2024
- 84 Pages
Global
From €3536EUR$3,950USD£3,012GBP
- Report
- January 2024
- 179 Pages
Global
From €7117EUR$7,950USD£6,062GBP
- Report
- July 2023
- 100 Pages
Global
From €4252EUR$4,750USD£3,622GBP
- Report
- April 2023
- 246 Pages
Global
From €6714EUR$7,500USD£5,719GBP

The Liver and Kidney Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs to treat diseases and disorders of the liver and kidneys. These drugs are used to treat a variety of conditions, including hepatitis, cirrhosis, kidney failure, and other kidney-related diseases. The market is highly competitive, with many companies vying for market share.
The market is driven by the increasing prevalence of liver and kidney diseases, as well as the development of new treatments and technologies. Additionally, the rising demand for better treatments and the increasing availability of generic drugs are also contributing to the growth of the market.
Some of the major companies in the Liver and Kidney Disorders Drugs market include Pfizer, Merck, Novartis, Sanofi, GlaxoSmithKline, AstraZeneca, Bristol-Myers Squibb, and AbbVie. These companies are engaged in the development and production of drugs to treat liver and kidney diseases. Show Less Read more